๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Synthesis of position-specific tritium-labeled 20(S)-camptothecin, 9-amino-20(S)-camptothecin, and 10,11-methylenedioxy-20(S)-camptothecin

โœ Scribed by Allan W. Nicholas; Mansukh C. Wani; Monroe E. Wall; John A. Kepler; George F. Taylor


Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
474 KB
Volume
33
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

The synthesis is given for three ring A tritiated camptothecin (CPT) analogs as biological probes in the study of the parent compounds which are of current widespread interest as potent anticancer agents. The strategy of catalytic tritolysis of aryl halide bonds was employed, and thus the preparations of the requisite precursors 9โ€chloroโ€20(S)โ€CPT (9), 9โ€aminoโ€10,12โ€dibromoโ€20(S)โ€CPT (14), and 9โ€chloroโ€10,11โ€methylenedioxyโ€20(S)โ€CPT (18) are given; catalytic tritiation of these respective precursors under polar, alkaline solvent conditions using palladium/carbon provides smooth conversion to [9โ€^3^H]โ€20(S)โ€CPT (10), 9โ€aminoโ€[10,12โ€^3^H]โ€20(S)โ€CPT (15), and [9โ€^3^H]โ€10,11โ€methylenedioxyโ€20(S)โ€CPT (19).


๐Ÿ“œ SIMILAR VOLUMES


ChemInform Abstract: Novel C-Ring Analog
โœ Duvvuri Subrahmanyam; Akella Venkateswarlu; Kalla Venkateswara Rao; Tungathurty ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons โš– 33 KB ๐Ÿ‘ 2 views

## 2. Synthesis and in vitro Cytotoxicity of 5-C-Substituted 20(S)-Camptothecin Analogues. -A series of several 5-substituted camptothecin analogues [cf. (II), (IV), (VI)] are synthesized from the natural alkaloid (I) and evaluated for their in vitro anticancer activity. Some of these analogues, e

Synthetic Studies on Camptothecins. Part
โœ Yun-Yan Kuang; Jing-Ze Niu; Fen-Er Chen ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ German โš– 185 KB

## Abstract A concise and efficient asymmetric process for the total synthesis of (20__S__)โ€7โ€ethylโ€10โ€hydroxycamptothecin (=SNโ€38; **1f**), an active metabolic form of the prodrug irinotecan, is described. This approach features the enantioselective cyanosilylation of indolizinone **4** into the c